Abstract:Abstract Purpose: Telomeres play a key role in maintaining chromosome stability. Telomere length and genetic variations in maintenance genes may be associated with risk of lung cancer. A significant number of patients with non-small cell lung cancer (NSCLC) will develop recurrence after resection. To potentially identify this subgroup of patients, we hypothesized that telomere length in peripheral blood as well as genetic variations in maintenance genes would have significant predictive value for recurrence and survival after curative resection in NSCLC. Methods: This is a prospective study involving patients with early stage NSCLC who underwent resection at MD Anderson Cancer Center between 1991 and 2007. Relative telomere length (RTL) of peripheral leukocytes was measured by real-time PCR in 473 patients. 159 single nucleotide polymorphisms (SNPs) within 12 maintenance genes were genotyped in 467 patients who were treated with surgery only (N=340) or surgery and chemotherapy (N=127). The risk of recurrence was estimated as hazard ratios (HRs) and 95% confidence intervals (CIs) using a multivariable Cox proportional hazard regression model. Results: Long telomere length was associated with increased risk of recurrence (1.13 vs. 1.07, P=0.047). This increased risk was more pronounced in female (HR=2.25; 95% CI, 1.02-4.96, P=0.044) and adenocarcinoma subgroups (HR=2.19; 95% CI, 1.05-4.55, P=0.036). SNPs that were predictive of recurrence (P<0.05) were distributed into 3 different risk groups according to varying HRs when treated with surgery only or surgery plus chemo; A=should receive surgery only (HR<1 in surgery only and HR>1 in surgery+chemo); B=should receive surgery and chemo (HR>1 in surgery only and HR<1 in surgery+chemo); C=no benefit from either treatment (HR>1 in both groups). For example, patients with the 2 variant alleles of rs733396 had significantly increased risk of developing recurrence if treated with surgery alone (HR=1.85, 95% CI,1.04-3.29, P=0.036), but adding chemotherapy to patients with the same variant had a protective effect (HR=0.31, 95% CI, 0.09-1.04, P=0.057) thereby placing this variant into group B. In terms of survival, we categorized patients into favorable, intermediate and unfavorable groups based on the number of unfavorable genotypes they have. Unfavorable group (>9 unfavorable SNPs) had 3.23 fold increase in risk of overall death with median survival time (MST) of 55 months compared to favorable group (0-6 unfavorable SNPs) with MST of 136 months. Conclusions: Long telomere length is associated with increased risk of recurrence in early stage NSCLC after curative resection. Our proposed risk-prediction model using prognostic SNPs within telomere maintenance genes may be used to guide therapy and determine prognosis of patients following resection. [Supported by NCI CA 111646, CA 55769 and CA 70907] Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 102nd Annual Meeting of the American Association for Cancer Research; 2011 Apr 2-6; Orlando, FL. Philadelphia (PA): AACR; Cancer Res 2011;71(8 Suppl):Abstract nr 2249. doi:10.1158/1538-7445.AM2011-2249

Clinical significance of germline telomere length and associated genetic factors in patients with neuroblastoma

Discriminating Association of a Common Telomerase Reverse Transcriptase Promoter Polymorphism with Telomere Parameters in Non-Small Cell Lung Cancer with or Without Epidermal Growth Factor Receptor Mutation.

Leukocyte telomere length: a novel biomarker to predict the prognosis of glioma patients

Abstract 4873: Comprehensive Analysis of 160 Whole-Genome Sequences Reveals Striking Telomere Alteration Patterns in 9 Pediatric Cancers

Abstract 2745: Genetic Determinants of Telomere Length – a Genome Wide Association Study

Germline functional variants contribute to somatic mutation and outcomes in neuroblastoma

Molecular Mechanism of Telomere Length Dynamics and Its Prognostic Value in Pediatric Cancers

Association Between Leukocyte Telomere Length and Glioma Risk: a Case-Control Study.

Genetically determined telomere length is associated with pancreatic neuroendocrine neoplasms onset

Telomere maintenance and the etiology of adult glioma.

Association of Age at Diagnosis and Genetic Mutations in Patients with Neuroblastoma

Abstract 2249: Use of Telomere Length and Genetic Variations in Maintenance Genes to Predict Risk of Recurrence and Survival in Patients with Early-Stage Non-Small Cell Lung Cancer

Higher tumor mutational burden is associated with inferior outcomes among pediatric patients with neuroblastoma

Leukocyte Telomere Length Associated with Glioma Risk and Survival

Short NK- and Naïve T-Cell Telomere Length Is Associated with Thyroid Cancer in Childhood Cancer Survivors: A Report from the Childhood Cancer Survivor Study

Common Genetic Variants in NEFL Influence Gene Expression and Neuroblastoma Risk

Long Telomere Length Predicts Poor Clinical Outcome in Esophageal Cancer Patients.

Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

Telomere Length as a Prognostic Factor for Overall Survival in Colorectal Cancer Patients

Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) Report

Genome-Wide Linkage Analysis to Identify Genetic Modifiers of ALK Mutation Penetrance in Familial Neuroblastoma